Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results

Eli Lilly shares set a new 52-week high price after the company reported that its Verzenio® (abemaciclib) significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer. Eli Lilly and Co. (LLY:NYSE) today annou...
Streetwise Reports | June 17, 2020 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...
Streetwise Reports | December 30, 2019 |

Consolidating one of the largest advanced-stage, undeveloped gold projects in Canada

First Mining Gold Corp. a Canadian gold developer focused on the development and permitting of the Springpole Gold Project in northwestern Ontario, one of the largest undeveloped gold projects in...
Jonathon Brown | August 2, 2022 |

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |

Heritage Mining: a junior exploration company focused on advanced-stage precious and base metal proj

Heritage Mining is a junior mineral exploration company focused on its flagship district-scale Drayton-Black Lake property in northwestern Ontario. The Vancouver-based company’s executive team has over 100 years of collective experience in the industry...
Simon Druker | January 16, 2023 |

Heritage Mining: your connection to precious & base metal assets in mining friendly regions

Welcome to the Market Herald Video Q&A Podcast.Heritage Mining Limited is focused on acquiring and developing Tier-1 advanced stage precious and base metal exploration projects in mining...
Jonathon Brown | August 15, 2022 |

Gold Rallies As Fear Take Center Stage

Gold has rallied extensively from the lows near $1560 over the past 2 weeks. At first, this rally didn’t catch too much attention with traders, but now the rally has reached new highs above $1613 and may attempt a move above $1750 as metals continue to reflec...
Chris Vermeulen | February 21, 2020 |

Bringing Hope to People Living with Neurodegenerative Diseases

Alpha Cognition Inc. ( TSX-V.ACOG , OTCMKTS: ACOGF , Forum ) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases. Stockhouse Media’s Dave Jackson caught up recently with Company CE...
Dave Jackson | October 20, 2021 |

Gold sector: Current situation and per-ounce valuations

Below is an excerpt from a commentary originally posted at www.speculative-investor.com on December 18, 2011. Current market situation Last week's price action proved that the correction/consolidation in the gold sector that began in December of last year is stil...
Steven Saville | October 28, 2012 |
1 2 3 4 5 6 7 8 9 10 ...